272 related articles for article (PubMed ID: 10845752)
1. No evidence for multiple-drug prophylaxis for tuberculosis compared with isoniazid alone in Southeast Asian refugees and migrants: completion and compliance are major determinants of effectiveness.
MacIntyre CR; Ansari MZ; Carnie J; Hart WG
Prev Med; 2000 May; 30(5):425-32. PubMed ID: 10845752
[TBL] [Abstract][Full Text] [Related]
2. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival.
Moreno S; Miralles P; Diaz MD; Baraia J; Padilla B; Berenguer J; Alberdi JC
Arch Intern Med; 1997 Aug 11-25; 157(15):1729-34. PubMed ID: 9250234
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
4. 4 months of rifampin compared with 9 months of isoniazid for the management of latent tuberculosis infection: a meta-analysis and cost-effectiveness study that focuses on compliance and liver toxicity.
Ziakas PD; Mylonakis E
Clin Infect Dis; 2009 Dec; 49(12):1883-9. PubMed ID: 19911936
[TBL] [Abstract][Full Text] [Related]
5. Four-month, four-drug preventive therapy for inactive pulmonary tuberculosis.
Goldberg SV; Duchin JS; Shields T; Nolan CM
Am J Respir Crit Care Med; 1999 Aug; 160(2):508-12. PubMed ID: 10430721
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis in patients with systemic rheumatic or pulmonary diseases treated with glucocorticosteroids and the preventive role of isoniazid: a review of the available evidence.
Falagas ME; Voidonikola PT; Angelousi AG
Int J Antimicrob Agents; 2007 Dec; 30(6):477-86. PubMed ID: 17913470
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
Sterling TR; Brehm WT; Moore RD; Chaisson RE
Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327
[TBL] [Abstract][Full Text] [Related]
9. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
[TBL] [Abstract][Full Text] [Related]
10. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City.
Li J; Munsiff SS; Tarantino T; Dorsinville M
Int J Infect Dis; 2010 Apr; 14(4):e292-7. PubMed ID: 19656705
[TBL] [Abstract][Full Text] [Related]
11. Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
Hoopes AJ; Kammerer JS; Harrington TA; Ijaz K; Armstrong LR
Arch Intern Med; 2008 Oct; 168(18):1984-92. PubMed ID: 18852399
[TBL] [Abstract][Full Text] [Related]
12. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
[TBL] [Abstract][Full Text] [Related]
13. Active tuberculosis in individuals infected with human immunodeficiency virus after isoniazid prophylaxis.
Fitzgerald DW; Morse MM; Pape JW; Johnson WD
Clin Infect Dis; 2000 Dec; 31(6):1495-7. PubMed ID: 11096020
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy.
Mok MY; Lo Y; Chan TM; Wong WS; Lau CS
J Rheumatol; 2005 Apr; 32(4):609-15. PubMed ID: 15801014
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of prophylaxis against tuberculosis in patients infected with HIV].
Arbeláez MP; Arbeláez A; Gómez RD; Rojas C; Vélez L; Arias SL; Nagles J; Peláez LM; Betancourt G; Velásquez G
Biomedica; 2007 Dec; 27(4):515-25. PubMed ID: 18320119
[TBL] [Abstract][Full Text] [Related]
16. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy.
Vikrant S; Agarwal SK; Gupta S; Bhowmik D; Tiwari SC; Dash SC; Guleria S; Mehta SN
Transpl Infect Dis; 2005; 7(3-4):99-108. PubMed ID: 16390397
[TBL] [Abstract][Full Text] [Related]
17. Incidence of TB in inmates with latent TB infection: 5-year follow-up.
White MC; Tulsky JP; Menendez E; Goldenson J; Kawamura LM
Am J Prev Med; 2005 Nov; 29(4):295-301. PubMed ID: 16242592
[TBL] [Abstract][Full Text] [Related]
18. Tuberculosis in renal transplant recipients: the evidence for prophylaxis.
Currie AC; Knight SR; Morris PJ
Transplantation; 2010 Oct; 90(7):695-704. PubMed ID: 20647975
[TBL] [Abstract][Full Text] [Related]
19. A randomised controlled clinical trial of the efficacy of family-based direct observation of anti-tuberculosis treatment in an urban, developed-country setting.
MacIntyre CR; Goebel K; Brown GV; Skull S; Starr M; Fullinfaw RO
Int J Tuberc Lung Dis; 2003 Sep; 7(9):848-54. PubMed ID: 12971668
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of tuberculosis contacts investigation and treatment, especially of preventive therapy in infants and young children].
Kondo S; Ito M
Kekkaku; 2003 Nov; 78(11):677-82. PubMed ID: 14672044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
